Abstract

Abstract Cost-effectiveness analysis (CEA) in cardiac surgery continues to grow in relevance with increasing health care expenditures, a greater emphasis on value-based care, the continuing development of costly surgical and noninvasive technologies, advances in cardiac devices, and changes in eligibility criteria over the past two decades. Although the rapidly evolving surgical technologies pose challenges to CEA, improvements in gathering and leveraging long-term economic and clinical data alongside trials and in cardiac surgery registries represent future opportunities for the field. As such, it is important for cardiac surgeons to understand CEA with respect to existing and future surgical therapies. Herein, we review the fundamental principles of cost-effectiveness analysis theory and discuss recent cost-effectiveness studies on cardiac surgery.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.